
BioVie Inc.
BIVIWHealthcare|Biotechnology|US
$0.27
+0.02 (+6.20%)
Next Earnings Report
Dec 2, 2026
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Nov 5, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
SEC Filings (6)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 6, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Nov 6, 2026 | 8-K | Material event | DocumentIndex |
| Nov 6, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 5, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Nov 5, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Nov 4, 2026 | 424B5 | Offering prospectus | DocumentIndex |